Doctors and public health groups in India have come up with the suggestion that the government should work for the gradual phasing out of branded drugs in a calibrated manner along with the abolition of differential pricing under different brands to give a push to generic drug prescriptions, noted Brand India Pharma, an initiative led by Pharmexcil (Pharmaceutical Export Promotion Council) and IBEF (India Brand Equity Foundation) under the aegis of the Department of Commerce.
Prime Minister Narendra Modi had recently announced that the government was looking at a legal framework ensuring mandatory prescription of low cost generic medicines by doctors. Following the announcement, the Medical Council of India has stated that doctors should only prescribe generic medicines.
The proposal for mandatory prescription of generic medicines would, however, be useless and counterproductive if it is carried out as a stand-alone measure, according to the All India Drug Action Network (AIDAN). Phasing out of the branded drugs should be done gradually so that not only the doctors but also pharmacists are not able to promote specific brands.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze